Mc-MMAD

For research use only. Not for therapeutic Use.

  • CAT Number: I001534
  • CAS Number: 1401963-15-2
  • Molecular Formula: C51H77N7O9S
  • Molecular Weight: 964.26
  • Purity: ≥95%
Inquiry Now

Mc-MMAD (Cat No.:I001534) is a potent inhibitor of the enzyme methionine aminopeptidase 2 (MetAP2), which is involved in protein processing and angiogenesis. By inhibiting MetAP2, Mc-MMAD disrupts the removal of methionine from nascent proteins, influencing cellular functions and promoting apoptosis in cancer cells. This compound has shown efficacy in preclinical studies against various tumors, particularly in the context of anti-angiogenic therapies. Mc-MMAD’s mechanism of action and its potential therapeutic applications make it a significant focus in cancer research, particularly in developing targeted treatments for malignancies.


Catalog Number I001534
CAS Number 1401963-15-2
Synonyms

(S,Z)-2-(6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-methylhexanamido)-N-((S)-1-(((3R,4S,5S)-1-((S)-2-((1R,2R,Z)-3-hydroxy-1-methoxy-2-methyl-3-(((S)-2-phenyl-1-(thiazol-2-yl)ethyl)imino)propyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)(met

Molecular Formula C51H77N7O9S
Purity ≥95%
Target Microtubule/Tubulin
Solubility 10 mM in DMSO
Storage Store at -20°C
IUPAC Name 6-(2,5-dioxopyrrol-1-yl)-N-[(2S)-1-[[(2S)-1-[[(3R,4S,5S)-3-methoxy-1-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[[(1S)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-N-methylhexanamide
InChI InChI=1S/C51H77N7O9S/c1-12-34(6)46(56(9)51(65)44(32(2)3)54-49(64)45(33(4)5)55(8)40(59)23-17-14-18-27-58-41(60)24-25-42(58)61)39(66-10)31-43(62)57-28-19-22-38(57)47(67-11)35(7)48(63)53-37(50-52-26-29-68-50)30-36-20-15-13-16-21-36/h13,15-16,20-21,24-26,29,32-35,37-39,44-47H,12,14,17-19,22-23,27-28,30-31H2,1-11H3,(H,53,63)(H,54,64)/t34-,35+,37-,38-,39+,44-,45-,46-,47+/m0/s1
InChIKey OZUQLKHIIRUJRZ-PGBUMTRMSA-N
SMILES CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@@H](CC2=CC=CC=C2)C3=NC=CS3)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N(C)C(=O)CCCCCN4C(=O)C=CC4=O
Reference

<p style=/line-height:25px/>
<br>[1]. Antibody-drug conjugates Patent: WO 2013068874 A1
</p>

Request a Quote